Differential expression of miR-128 in memory T cells of patients with severe hemophilia A with and without inhibitors
Silvia Spena, Andrea Cairo, Emanuela Pappalardo, Calogero C. Tedesco, Roberta Gualtierotti, Flora Peyvandi · 2026
Read Differential expression of miR-128 in memory T cells of patients with severe hemophilia A with and without inhibitors by Silvia Spena, Andrea Cairo, Emanuela Pappalardo, Calogero C. Tedesco, Roberta Gualtierotti, Flora Peyvandi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13343139.txt.
Description
Silvia Spena and co-authors measure a small RNA molecule in blood cells of people with severe hemophilia A. Their 2026 study asks whether this molecule, miR-128, differs between patients who develop inhibitors and those who do not. Inhibitors are antibodies that block the clotting factor treatment, and they arise in about thirty percent of patients.
Forty-five patients took part, grouped by whether their inhibitor was lasting, passing, or absent. Levels of miR-128 ran higher in blood cells of patients with inhibitors. The gap was largest in memory T cells of patients with lasting inhibitors, at nearly four times the level. The authors suggest this RNA helps steer T cell growth in the inhibitor response.
Catalog record
| CREATOR | Silvia Spena, Andrea Cairo, Emanuela Pappalardo, Calogero C. Tedesco, Roberta Gualtierotti, Flora Peyvandi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |